BioNTech SE (BNTX) Cash from Operations (2018 - 2025)
BioNTech SE (BNTX) posted Cash from Operations of 360271467.8 for Q4 2025, up 143.87% on a QoQ basis from 821206181.94 in Q1 2025, and up 172.77% year-over-year from 132078692.22 in Q4 2024.
BioNTech SE (BNTX) has 8 years of Cash from Operations data on file, last reported at 360271467.8 in Q4 2025.
- In Q4 2025, Cash from Operations rose 172.77% year-over-year to 360271467.8; the TTM figure through Dec 2025 stood at 796296501.11 (down 56.44% YoY), while the FY2025 annual figure was 515193902.59, up 132.12% from the prior year.
- Cash from Operations rose to 360271467.8 in Q4 2025, from 821206181.94 in the prior quarter.
- Across five years, Cash from Operations topped out at 4818442194.59 in Q3 2022 and bottomed at 821206181.94 in Q1 2025.
- A 5-year average of 1136509610.56 and a median of 610745208.3 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations surged 3362.17% — and 2024, when it slumped 154.08%.
- Year by year, Cash from Operations stood at 228222204.75 in 2021, then soared by 470.69% to 845989115.3 in 2022, then climbed by 8.22% to 915517268.55 in 2023, then sank by 154.08% to 495080248.9 in 2024, then surged by 172.77% to 360271467.8 in 2025.
- The last three Cash from Operations figures came in at 360271467.8 (Q4 2025), 821206181.94 (Q1 2025), and 495080248.9 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 360.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 360.27 Mn |
| Dec 31, 2025 | 360.27 Mn |
| Mar 31, 2025 | -821.21 Mn |
| Mar 31, 2025 | -821.21 Mn |
| Dec 31, 2024 | -495.08 Mn |
| Dec 31, 2024 | -495.08 Mn |
| Jun 30, 2024 | 1.75 Bn |
| Jun 30, 2024 | 1.75 Bn |
| Mar 31, 2024 | -344.70 Mn |
| Mar 31, 2024 | -344.70 Mn |
| Dec 31, 2023 | 915.52 Mn |
| Dec 31, 2023 | 915.52 Mn |
| Sep 30, 2023 | 883.06 Mn |
| Sep 30, 2023 | 883.06 Mn |
| Jun 30, 2023 | 4.78 Bn |
| Jun 30, 2023 | 4.78 Bn |
| Mar 31, 2023 | -727.08 Mn |
| Mar 31, 2023 | -727.08 Mn |
| Dec 31, 2022 | 845.99 Mn |
| Dec 31, 2022 | 845.99 Mn |
| Sep 30, 2022 | 4.82 Bn |
| Sep 30, 2022 | 4.82 Bn |
| Jun 30, 2022 | 4.18 Bn |
| Jun 30, 2022 | 4.18 Bn |
| Dec 31, 2021 | -228.22 Mn |
| Dec 31, 2021 | -228.22 Mn |
| Sep 30, 2021 | 1.77 Bn |
| Sep 30, 2021 | 1.77 Bn |
| Jun 30, 2021 | 120.79 Mn |
| Jun 30, 2021 | 120.79 Mn |
| Mar 31, 2021 | 375.50 Mn |
| Mar 31, 2021 | 375.50 Mn |
| Dec 31, 2020 | -329.36 Mn |
| Dec 31, 2020 | -329.36 Mn |
| Sep 30, 2020 | 224.90 Mn |
| Sep 30, 2020 | 224.90 Mn |
| Jun 30, 2020 | 17.07 Mn |
| Jun 30, 2020 | 17.07 Mn |
| Mar 31, 2020 | 60.39 Mn |
| Mar 31, 2020 | 60.39 Mn |
| Dec 31, 2019 | -369.05 Mn |
| Dec 31, 2019 | -369.05 Mn |
| Sep 30, 2019 | 54.77 Mn |
| Sep 30, 2019 | 54.77 Mn |
| Jun 30, 2019 | 61.21 Mn |
| Jun 30, 2019 | 61.21 Mn |
| Mar 31, 2019 | 35.48 Mn |
| Mar 31, 2019 | 35.48 Mn |
| Dec 31, 2018 | -63.18 Mn |
| Dec 31, 2018 | -63.18 Mn |